PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 193 filers reported holding PDL BIOPHARMA INC in Q4 2016. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $117,000 | -29.5% | 35,935 | -26.8% | 0.00% | -77.8% |
| Q3 2017 | $166,000 | +124.3% | 49,062 | +64.0% | 0.01% | +80.0% |
| Q2 2017 | $74,000 | +89.7% | 29,918 | +73.4% | 0.01% | +66.7% |
| Q1 2017 | $39,000 | -65.2% | 17,253 | -67.5% | 0.00% | -66.7% |
| Q4 2016 | $112,000 | +34.9% | 53,051 | +114.2% | 0.01% | +80.0% |
| Q3 2016 | $83,000 | -17.8% | 24,771 | -23.3% | 0.01% | -16.7% |
| Q2 2016 | $101,000 | +34.7% | 32,310 | +43.5% | 0.01% | +50.0% |
| Q1 2016 | $75,000 | -9.6% | 22,516 | -4.0% | 0.00% | -20.0% |
| Q4 2015 | $83,000 | -22.4% | 23,445 | +10.5% | 0.01% | 0.0% |
| Q3 2015 | $107,000 | – | 21,212 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 2,632,000 | $8,817,000 | 2.83% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 551,804 | $1,848,543,000 | 1.54% |
| Nine Chapters Capital Management LLC | 24,300 | $81,000 | 0.57% |
| GREAT POINT PARTNERS LLC | 645,000 | $2,161,000 | 0.55% |
| Virtus ETF Advisers LLC | 198,901 | $666,000 | 0.32% |
| GSA CAPITAL PARTNERS LLP | 1,521,224 | $5,096,000 | 0.27% |
| Amici Capital, LLC | 200,000 | $670,000 | 0.18% |
| Acrospire Investment Management LLC | 70,622 | $237,000 | 0.16% |
| RBF Capital, LLC | 273,976 | $918,000 | 0.16% |
| SECOR Capital Advisors, LP | 383,971 | $1,286,000 | 0.14% |